Psound Bytes Pro: Recent Episodes
National Psoriasis Foundation
National Psoriasis Foundation presents Psound Bytes Pro, a podcast series featuring leading experts discussing recognizing, diagnosing, and managing psoriasis and/or psoriatic arthritis. Listen to world-renowned dermatologists and rheumatologists discuss the latest news in psoriatic disease management.
Hear from Dr. Mark Lebwohl, MD, Dean for Clinical Therapeutics at the Icahn School of Medicine at Mount Sinai and Professor and Chairman Emeritus of the Kimberly and Eric J. Waldman Department of Dermatology, and Dr. Jason Hawkes, M.D., M.S., co-owner, CSO, and principal investigator at the Oregon Medical Research Center, discuss the intersection of obesity, psoriasis, and GLP-1s.
This podcast was brought to you by Lilly.
Dr. Amy Paller, pediatric dermatologist and clinical researcher at Northwestern Feinberg School of Medicine, and Dr. Ronald Prussick, MD, dermatologist at the Washington Dermatology Center and Vice Chair of the NPF Medical Board, discuss psoriasis and eczema comorbidities in pediatric and adult patients. This podcast is presented in collaboration with the National Eczema Association.
This podcast is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $375,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.
Dr. Bruce Strober, MD, PhD, dermatologist and JPPA Editor-in-Chief, and Guy Eakin, PhD, Chief Science and Medical Officer at the NPF discuss the Journal of Psoriasis and Psoriatic Arthritis path to indexing and what it means for the research community moving forward. This podcast is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $375,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.
Hear dermatologists Dr. Kristina Duffin, MD, MS, Professor and Chair of the Department of Dermatology at the University of Utah and Dr. Joel Gelfand, MD, MSCE, FAAD, Director, Psoriasis & Phototherapy Treatment Center at Penn, discuss the Light Treatment Effectiveness (LITE) Study and the data presented at the 2024 AAD Annual Meeting.
The LITE Study is funded with support from the Patient-Centered Outcomes Research Institute (PCORI), an independent research institute authorized by Congress to fund comparative clinical effectiveness research that engages patients and other stakeholders in the research process. This study also benefited from the Daavlin Company’s contribution of the phototherapy machines on behalf of this study.
This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $351,404, with 2 percentage funded by CDC/HHS and $14.3 million amount and 98 percentage funded by non-government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.
Hear gastroenterologist Dr. Lisa Malter, Professor at the Department of Medicine at NYU Grossman School of Medicine, discuss the intersection between psoriasis and IBD.
This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $326,934 with 3 percentage funded by CDC/HHS and $100,000 amount and 12 percentage funded by non- government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.
Hear rheumatologist Dr. Lihi Eder from the University of Toronto discuss diagnostic biomarkers and the use of imaging to diagnose psoriatic arthritis.
This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $326,934 with 3 percentage funded by CDC/HHS and $100,000 amount and 12 percentage funded by non- government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.
This program is supported by educational grants from AbbVie and Novartis.
Hear Dr. Ron Prussick, from the Washington Dermatology Center, discuss the importance of diet in patients living with psoriasis.
This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $326,934 with 3 percentage funded by CDC/HHS and $100,000 amount and 12 percentage funded by non- government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.
This program is supported by educational grants from AbbVie and Novartis.
Can accountability and gamification improve treatment adherence? Hear Dr. Steven Feldman, Professor at Wake Forest University School of Medicine, discuss this and more.
This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $326,934 with 3 percentage funded by CDC/HHS and $100,000 amount and 12 percentage funded by non- government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.
This program is supported by educational grants from AbbVie and Novartis.
Patients living with psoriasis may have an increased risk of certain infections, but also certain infections can trigger or exacerbate psoriasis symptoms. Listen to dermatologist, Dr. Seth Forman, and his patient Katie Chambers as they discuss the intersection of infection and PsO.
This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $326,934 with 3 percentage funded by CDC/HHS and $100,000 amount and 12 percentage funded by non- government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.
This program is supported by educational grants from AbbVie and Novartis.
Although rare, erythrodermic psoriasis can be life-threatening. Listen to Dr. Mio Nakamura, Assistant Professor of Dermatology at the University of Michigan discusses this severe variant of psoriasis vulgaris.
This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $326,934 with 3 percentage funded by CDC/HHS and $100,000 amount and 12 percentage funded by non- government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.
This program is supported by educational grants from AbbVie and Novartis.
Hear Dr. Mona Shahriari, M.D., Assistant Clinical Professor of Dermatology at Yale University School of Medicine, the Associate Director of Clinical Trials at CCD Research and a senior editor for the Journal of Psoriasis and Psoriatic Arthritis, discuss discuss diagnosis and managing psoriasis in people with skin of color.
This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $326,934 with 3 percentage funded by CDC/HHS and $100,000 amount and 12 percentage funded by non- government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.
This program is supported by educational grants from AbbVie and Novartis.
Hear Shawn Kwatra, M.D., Associate Professor, Department of Dermatology at Wake Forest School of Medicine and Director of John Hopkins Itch Center, discuss pathogenesis of itch, histaminergic pathways, treatments and more.
This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $326,934 with 3 percentage funded by CDC/HHS and $100,000 amount and 12 percentage funded by non-government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HSS, or the U.S. government.
This program is supported by educational grants from AbbVie and Novartis.
Hear Bridget Myers is a resident at UC Davis Dermatology and first-place winner of the abstract competition at the 2022 Annual Residents’ Meeting to discuss the complex relationship between sleep and the gut microbiome in psoriasis.
For volunteer appreciation month, hear Dr. Meyer Horn, Medical Director, Dermatology and Aesthetics in Chicago and Julia Hamel, NPF Midwest Regional Development Manager discuss the importance of patients and providers volunteering with the NPF. Dr. Horn also shares his strategies for success.
Hear Jason Harris, NPF's VP of Government Relations & Advocacy, discuss treatment access and barriers with Dr. Jason Hawkes from UC Davis and Dr. G. Michael Lewitt from Illinois Dermatology Institute.
This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $326,934 with 3 percentage funded by CDC/HHS and $100,000 amount and 12 percentage funded by non- government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.
Join us for another Psound Bytes™ CME Journal Club episode discussing noteworthy publications in psoriatic disease. In this episode, we sit down with Dr. Larry Green from George Washington University to discuss recent research related to topical treatments and psoriasis.
For credit and disclosures, please visit: https://www.eeds.com/em/5751
This program is supported by educational grants from Amgen, Novartis, Janssen, and Pfizer.
Hear Dr. Steve Feldman, M.D., Professor, Department of Dermatology at Wake Forest School of Medicine, continue the discussion on psoriatic disease research and the latest treatment updates. This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $326,934 with 3 percentage funded by CDC/HHS and $100,000 amount and 12 percentage funded by non- government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government. This program is supported by educational grants from Amgen, Novartis, Pfizer, and UCB.
Hear Dr. Steve Feldman, MD, Professor, Department of Dermatology at Wake Forest School of Medicine, discuss psoriatic disease research and treatment updates.
This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $326,934 with 3 percentage funded by CDC/HHS and $100,000 amount and 12 percentage funded by non- government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.
This program is supported by educational grants from Amgen, Novartis, Pfizer, and UCB.
Hear Vanessa Cutler, M.D., Clinical Assistant Professor, Department of Psychiatry at NYU Grossman School of Medicine, discuss the impacts body dysmorphic disorder has on patients living with psoriatic disease.
This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $326,934 with 3 percentage funded by CDC/HHS and $100,000 amount and 12 percentage funded by non-government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.
This program is supported by educational grants from Amgen, Novartis, Pfizer and UCB.
Join us for another Psound Bytes™ CME Journal Club episode discussing noteworthy publications in psoriatic disease. In this episode, we continue to discuss recent research related to CBD and psoriatic disease with Dr. Adam Friedman from George Washington University and Dr. Jason Hawkes from UC Davis Health.
This program is supported by educational grants from Amgen, Novartis, Janssen, and Pfizer.
Join us for another Psound Bytes™ CME Journal Club episode discussing noteworthy publications in psoriatic disease. In this episode, we discuss recent research related to CBD and psoriatic disease with Dr. Adam Friedman from George Washington University and Dr. Jason Hawkes from UC Davis Health.
This program is supported by educational grants from Amgen, Novartis, Janssen, and Pfizer.
In the second of this 2- part series, Dr. David Rosmarin, M.D., MAS, assistant professor at Tufts University School of Medicine, continues to share insights into psoriasis for primary care providers.
This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $326,934 with 3 percentage funded by CDC/HHS and $100,000 amount and 12 percentage funded by non-government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.
This program is supported by educational grants from Amgen, Novartis, Pfizer, and UCB.
Hear Dr. David Rosmarin, M.D., MAS, assistant professor at Tufts University School of Medicine, provide an overview of psoriasis for primary care providers.
This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $326,934 with 3 percentage funded by CDC/HHS and $100,000 amount and 12 percentage funded by non- government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.
This program is supported by educational grants from Amgen, Novartis, Pfizer, and UCB.
Hear rheumatologist Dr. Atul Deodhar from OHSU in Portland, OR discuss how treatments for PsA and SpA should be used optimally in clinical practice while patients John Latella and Roz Tolliver share their disease experiences and how they manage treatment changes. This is the final CME episode in CAPES (Clinician and Patient Education Series) presented by NPF, GRAPPA, SPARTAN and SAA. This program is supported by an educational grant from Pfizer Inc.
Managing chronic pain and fatigue in patients with PsA and spondyloarthritis can be challenging for providers. Hear rheumatologists Dr. Philip Mease (Director, Rheumatology Research Swedish Medical Center/Providence St. Joseph Health) and Dr. Ernest Choy (Cardiff University School of Medicine), and patients Melissa Leeolou and Minionette "Mini" Wilson discuss causes, symptoms, risks and the latest in managing chronic pain and fatigue successfully. This is the second of three CME episodes in CAPES (Clinician and Patient Education Series) presented by NPF, GRAPPA, SPARTAN and SAA. This program is supported by an educational grant from Pfizer Inc.
Join us for another Psound Bytes Journal Club episode discussing noteworthy publications in psoriatic disease. In this episode, we discuss recent research related to adipokines and psoriasis with Dr. Nehal Mehta from George Washington University.
This program is supported by educational grants from Amgen, Novartis, Janssen, and Pfizer.
Join pediatric rheumatologist Dr. Dax Rumsey from the Stollery Children's Hospital and University of Alberta, alongside patients Wendy Olsder, Asad Khan and Aamena Hameed, as they discuss the spectrum and classification of JSpA and JPsA and what it means to live with JSpA and JPsA. This is the first of three CAPES (Clinician and Patient Education Series) podcast episodes presented by NPF, GRAPPA, SPARTAN and SAA.
This program is supported by an educational grant from Pfizer.
For credit and disclosures, please visit: https://www.eeds.com/em/4688
Hear Dr. Tina Bhutani, M.D., MAS, assistant professor at the University of California San Francisco, discuss the impacts psoriatic disease has on underserved minorities.
For credit and disclosures, visit: https://www.eeds.com/em/4708
This program is supported by educational grants from Amgen, Novartis, Pfizer, and UCB.
Hear cardiologist, Dr. Michael Garshick, and NPF Director of Research & Medical Affairs, Dr. Bob Friesel, discuss endothelial inflammation and the connections between cardiac inflammation and psoriasis.
This program is supported by educational grants from Amgen, Novartis, Pfizer, and UCB.
Listen as Dr. Dafna Gladman, Professor of Medicine at the University of Toronto and Senior Scientist at the Toronto Western Research Institute, discuss available PsA screening tools.
This program is supported by educational grants from Amgen, Novartis, Pfizer, and UCB.
Dr. Paras Karmacharya, Vanderbilt University Medical Center, continues his discussion of psoriatic arthritis (PsA) in this second installment in our new PCP series! This series aims to help educate primary care providers (PCPs) about psoriatic disease, particularly as the rheumatologist shortage continues to impact the role of PCPs in diagnosing psoriasis and PsA.
Psound Bytes CME is supported by education grants from Amgen, Novartis, Pfizer, and UCB.
Hear rheumatologist Dr. Paras Karmacharya, from Vanderbilt University Medical Center, discuss PsA in this first installment in our new PCP series!
This podcast was supported by the CDC of the HHS as part of a financial assistance award totaling $326,934 with 3% funded by CDC/HHS and $100,000 amount and 12% funded by non-government source(s).
And our sponsors: Amgen, Novartis, Pfizer, and UCB
Listen to Dr. Nehal Mehta, Senior Investigator at the NHLBI, discuss how psoriasis can affect cardiovascular disease risk
Description: Join us for another Psound Bytes Journal Club episode discussing noteworthy publications in psoriatic disease. In this episode, we discuss recent research related to vaccination with Dr. Sandy Chat from Indiana University School of Medicine. For disclosures/credit, please visit https://www.eeds.com/em/3836. This program is supported by educational grants from AbbVie, Amgen, Janssen and UCB.
Join us for another Psound Bytes Journal Club episode discussing noteworthy publications in psoriatic disease. In this episode, we discuss recent research related to vaccination with Dr. Sandy Chat from Indiana University School of Medicine.
For disclosures/credit, please visit https://www.eeds.com/em/3829. This program is supported by educational grants from AbbVie, Amgen, Janssen and UCB.
Join us for another Psound Bytes Journal Club episode discussing noteworthy publications in psoriatic disease. In this episode, we discuss recent research and advancements with JAK inhibitors with Dr. Andrew Blauvelt, President, Oregon Medical Research Center in Portland, OR.
For credit/disclosures, please visit: https://www.eeds.com/em/3760 This program is supported by educational grants from AbbVie, Amgen, Janssen and UCB.
Hear Dr. Joel Gelfand, Vice Chair of Clinical Research and Medical Director, Dermatology Clinical Studies Unit and Director, Psoriasis and Phototherapy Treatment Center, discuss the use of phototherapy as a treatment for psoriasis and give us an update on the LITE Study.
For credit/disclosures: https://www.eeds.com/em/3705. This program is supported by educational grants from AbbVie, Novartis, Pfizer and UCB.
Hear Dr. Kelly Cordoro, Professor of Dermatology and Pediatrics at the University of California and Dr. Matthew Stroll, Associate Professor of Pediatrics in the division of Pediatric Rheumatology at Children's of Alabama as they discuss the unique features of pediatric psoriatic disease and recap the 2021 NPF Pediatric Derm/Rheum collaborative.
For disclosures/credit: https://www.eeds.com/em/3629. This program is supported by educational grants from Bristol Myers Squibb, Lilly, Novartis and Ortho Dermatologics.
Hear Dr. Jenny Murase, Associate Clinical Professor of Dermatology at the University of California, San Francisco (also known as UCSF) and the Director of Medical Consultative Dermatology at the Palo Alto Medical Foundation in Mountain View, CA discuss family planning and the impact of psoriasis. For disclosures/credit: https://www.eeds.com/em/3621. This program is supported by educational grants from Bristol Myers Squibb, Lilly, Novartis and Ortho Dermatologics.
Listen to dermatologist Dr. April Armstrong and rheumatologist Dr. Philip Mease as they discuss managing psoriasis and psoriatic arthritis in aging populations. For disclosures/credit: https://www.eeds.com/em/3582
This program is supported by educational grants from Bristol Myers Squibb, Lilly, Novartis and Ortho Dermatologics.
Hear Dermatologist Dr. Di Yan from NYU Langone Health discuss recent advancements in psoriatic comorbidities and targeted therapies. For disclosures/credit: https://www.eeds.com/em/3557. This program is supported by educational grants from Bristol Myers Squibb, Lilly, Novartis and Ortho Dermatologics.
Dermatologist and NPF Scientific Advisory Committee member Dr. Samuel Hwang from the University of California, Davis discusses how diet and lifestyle, including the Western Diet, affects psoriatic inflammation and recent advancements in related research. For disclosures/credit: https://www.eeds.com/em/3524. This program is supported by educational grants from Bristol Myers Squibb, Lilly, Novartis and Ortho Dermatologics.
Listen to Board Certified Dermatologist & Psychiatrist, Dr. Evan Rieder from NYU Langone in NYC, as he discusses considerations and tips for managing men's skin health, and the impact psoriasis may have on mental and sexual health. For disclosures/credit: https://www.eeds.com/em/3503. This program is supported by educational grants from Bristol Myers Squibb, Lilly, Novartis and Ortho Dermatologics.
Hear Dr. Sandy Chat from Indiana University School of Medicine and Dr. Christoph Ellebrecht, Clinical Instructor, Dept. of Dermatology at University of Pennsylvania, discuss the flu, shingles and mRNA vaccines and how psoriatic disease treatment can impact vaccine choices.
For disclosures/credit: https://www.eeds.com/em/3419.
This program is supported by educational grants from Bristol Myers Squibb, Lilly, Novartis and Ortho Dermatologics.
Half of those with psoriasis have undiagnosed cardiovascular risk factors. Hear how to go beyond the skin or joint disease to address associations with psoriatic disease with dermatologist Dr. John Barbieri, Brigham and Women’s Hospital in Boston, and NPF Board Chair Ron Grau.
For disclosures/credit: https://www.eeds.com/em/3354. This program is supported by educational grants from Bristol Myers Squibb, Lilly, Novartis and Ortho Dermatologics.
Hear dermatologist and NPF Medical Board Member Dr. G. Michael Lewitt from Illinois Dermatology Institute in Chicago discuss the presentation, tips for diagnosis, management strategies and treatment cautions for plaque, guttate, inverse, pustular and erythrodermic psoriasis. For disclosures/credit: https://www.eeds.com/em/3269 . This program is supported by educational grants from Bristol Myers Squibb, Lilly, Novartis and Ortho Dermatologics.
Can microbiome dysbiosis trigger inflammatory diseases like psoriasis and PsA, and can it be modified? Hear rheumatologist Dr. Jose Scher, Director, Psoriatic Arthritis Center, and Director of the Microbiome Center for Rheumatology and Autoimmunity, NYU Langone Health, explore such questions and more. Disclosures/credit: https://www.eeds.com/em/3241. This program is supported by educational grants from Bristol Myers Squibb, Lilly, Novartis and Ortho Dermatologics.
Hear leading dermatologist and geneticist Dr. James T. Elder, Kirk D. Wuepper Professor of Molecular Genetic Dermatology, University of Michigan, Dept. of Dermatology, explain genetic components like A20, ERAP1, ADAMSL5 and their role in the development of psoriatic disease. For disclosures/credit: https://www.eeds.com/em/3121. This program is supported by educational grants from Bristol Myers Squibb, Lilly, Novartis and Ortho Dermatologics.
Explore the latest insights in genetics, immunology, pathophysiology and how research is evolving with dermatologist Dr. Wilson Liao, Professor and Vice Chair of Research at UCSF Dept. of Dermatology, NPF Medical Board member and Chair of NPF Scientific Advisory Committee. For disclosures/credit: https://www.eeds.com/em/3014. This program is supported by educational grants from Bristol Myers Squibb, Lilly, Novartis and Ortho Dermatologics.
Listen as Pam Bohling, Physical Therapist and Orthopedic Clinical Specialist, Mountain States Hand & Physical Therapy in CO, and Dr. Stacie Bell, NPF Chief Scientific and Medical Officer discuss strategies for self-care, building strength and flexibility to help reduce pain in PsA. Disclosures/credit: https://www.eeds.com/em/2982. This program is supported by educational grants from Bristol Myers Squibb, Lilly, Novartis and Ortho Dermatologics.
Diagnosing and treating uncommon areas affected by psoriasis can be challenging. Hear Dr. Robert Kalb, Clinical Professor, Dept of Dermatology at SUNY, Buffalo School of Medicine in Buffalo, NY, address such hard-to-treat areas as the eyes, ears and mouth. For disclosures/credit: https://www.eeds.com/em/2927. This program is supported by educational grants from Bristol Myers Squibb, Lilly, Novartis and Ortho Dermatologics.
Hear Dr. Stacie Bell, Chief Scientific and Medical Officer at the NPF discuss palmoplantar psoriasis, dactylitis, enthesitis, plantar faciitis and more with podiatrist and foot and ankle surgeon Dr. Matthew Paden from Rocky Mountain Foot and Ankle Center in Wheat Ridge, CO. Disclosures/credit: https://www.eeds.com/em/2872. This program is supported by educational grants from Lilly, Bristol Myers Squibb, Novartis and Ortho Dermatologics.
Psoriasis classification is more than a BSA or PASI score. Listen as Dr. Bruce Strober, Clinical Professor of Dermatology at Yale University, New Haven, CT, and Dr. Andrew Blauvelt, President, Oregon Medical Research Center in Portland, OR, discuss the International Psoriasis Council's rationale for changing psoriasis severity classification for treatment decisions and clinical trials. Disclosures/credit: https://www.eeds.com/em/2833. Article link: www.psoriasis.org/watch-and-listen . This program is supported by educational grants from Lilly, Bristol Myers Squibb and Novartis.
.
At high risk for depression, about 60% of people with psoriasis also have sleep disturbances. Listen as dermatologist Dr. Tina Bhutani, Director of the Dermatology Clinical Research Unit at UCSF, explores the bi-directional relationship and implications for clinical care. Disclosures/credit: https://www.eeds.com/em/2635. This program is supported by educational grants from Bristol Myers Squibb, Lilly, Novartis and Ortho Dermatologics.
Biologic Fulfillment Fundamentals (BFF) Campaign from the NPF, sponsored by Janssen, supports dermatology biologic coordinators working to help psoriasis patients start and stay on their biologic treatment. Hear Joe Holton and Toby Thomas discuss what biologic coordinators and patients need to know about different types of insurance plans and prior authorizations when prescribed a biologic treatment.
For more information, visit psoriasis.org/BFF.
Psoriasis can look different in darker skin types making it a challenge to diagnose. World-renowned dermatologist and expert in skin of color, Dr. Seemal Desai from Innovative Dermatology in Plano, TX, addresses the presentation, diagnosis and treatment of psoriasis in skin of color. Disclosures/credit: https://www.eeds.com/em/2256. This program is supported by educational grants from Lilly, Bristol Myers Squibb and Novartis.
Hear dermatologist Dr. Mark Lebwohl, Mt. Sinai Health System, cardiologist Dr. Nehal Mehta and Dr. Heather Teague from the NIH Section of Inflammation and Cardiometabolic Diseases discuss the effect of systemic psoriasis treatments on CVD, diabetes and psoriatic arthritis. For disclosures/credits: https://www.eeds.com/em/2172. This program is supported by educational grants from AbbVie, Amgen, Janssen and UCB. To access articles mentioned https://bit.ly/2MKjlrB .
COVID-19 Task Force Co-Chairs dermatologist Dr. Joel Gelfand, Psoriasis & Phototherapy Treatment Center at PENN, and rheumatologist Dr. Christopher Ritchlin, Psoriasis Center, University of Rochester Medical Center, return to discuss the new vaccines and their use with psoriatic disease treatments. Disclosures/credit: https://www.eeds.com/em/1920. This program is supported by educational grants from Lilly, Bristol Myers Squibb and Novartis.
Perhaps five percent of people with psoriasis experience guttate psoriasis which occurs acutely. Dr. Steven Feldman, Wake Forest School of Medicine in Winston-Salem, NC, discusses characteristics, differential diagnoses, the connection to strep throat and effective treatment options. For disclosures and credit: https://www.eeds.com/em/1865. This program is supported by unrestricted educational grants from AbbVie, Lilly and Ortho Dermatologics.
Meeting the needs of patients with GPP, PPP or PPPP can be challenging. Listen as Dr. Kristina Callis Duffin, Chair, Department of Dermatology at the University of Utah, discusses challenges from evaluation, the IL-36RN gene, triggers, types, current treatment and what's in the pipeline. For disclosures and credit: https://www.eeds.com/em/1784. This program is supported by unrestricted educational grants from AbbVie, Lilly and Ortho Dermatologics.
Listen as dermatologist and rheumatologist Dr. Joseph Merola, Brigham and Women's Hospital in Boston, discusses the complexities of diagnosis, impact, efficacy of treatments and normalization of genital and inverse psoriasis. For disclosures and credit: https://www.eeds.com/em/1756. This program is supported by unrestricted educational grants from AbbVie, Lilly and Ortho Dermatologics.
Inclusion of diversity can impact design, recruitment, informed consent and data in clinical trials. Listen as rheumatologist Dr. Niti Goel, Duke University School of Medicine, Durham, NC, addresses issues tied to diversity and what can be done to improve inclusion in clinical trials. For disclosures and to claim credit go to https://www.eeds.com/em/1732. This program is supported by an unrestricted educational grant from Amgen.
Listen as dermatologist Dr. Elizabeth Prater, Medical Director, Healthy Skin Dermatology in Oklahoma City, addresses the latest guidelines and factors that impact use of topical therapies and alternative medicine modalities. For disclosures and to claim .25 CME credits complete the online post evaluation at cme.psoriasis.org, enduring materials. This program is supported by unrestricted educational grants from Celgene and Ortho Dermatologics.
Given the pandemic and need for clarity, NPF developed a COVID-19 Task Force. Listen as Co-Chairs, dermatologist Dr. Joel Gelfand, Director, Psoriasis and Phototherapy Treatment Center at Penn, and rheumatologist Dr. Christopher Ritchlin, Co-Director, Psoriasis Center, University of Rochester Medical Center in New York, discuss the evidence and content of NPF's 22 guidance statements addressing effects, risks, and best practices for treatment of patients with psoriatic disease. For disclosures and to claim credit, go to https://www.eeds.com/em/1545.
Hear pulmonologist, Dr. Albert Rizzo, Chief Medical Officer at the American Lung Association and member of Christiana Care Pulmonary Associates, and Deb Brown, Chief Mission Officer also with ALA, address the toxic impact of smoking on inflammatory diseases such as psoriasis. This episode includes a free smoking cessation program offer for patients. For disclosures and to claim credit, go to https://bit.ly/2QqzJeM.
Join us for our new Psound Bytes Journal Club series discussing noteworthy publications in psoriatic disease. In this first episode we discuss three recent trial results for therapeutics in the pipeline with dermatologists Dr. Mark Lebwohl, Professor and Chairman, Dept. of Dermatology, Icahn School of Medicine, Mt. Sinai Health System in New York, and Dr. Andrew Blauvelt, President, Oregon Medical Research Center in Portland, OR. For disclosures and to claim .5 CME credits go to cme.psoriasis.org. For publication links: https://bitly.31a6a7s
Hear preliminary data and how to participate in PsoProtect, an international registry for health care providers, from Dr. Catherine Smith, Professor of Dermatology and Therapeutics/Consultant Dermatologist, and Dr. Satveer Mahil, a Consultant Dermatologist, at St.. John's Institute of Dermatology, Kings College London. Help advance an understanding of how risk factors, immunomodulatory therapies and comorbidities affect COVID-19 outcomes in people with psoriasis and psoriatic arthritis, and how data results may impact clinical decisions.
Hear tips for maximizing psoriasis care from one of the country's leading experts in teledermatology, Dr. George Han, System Medical Director for Dermatology at Mount Sinai Health System and Chief of Teledermatology at Icahn School of Medicine at Mount Sinai. Listen as Dr. Han addresses access issues, system types and set-up, appointment challenges and reimbursement. To view disclosure information and claim credit go to https://www.eeds.com/em/1400. This program is supported by charitable contributions from Amgen, Janssen Pharmaceutical Companies of Johnson & Johnson, and Novartis.
Hear George Han, M.D. of the Icahn School of Medicine at Mt. Sinai, and Mark Kaufmann, M.D., President-Elect at the American Academy of Dermatology, discuss the new normal for dermatologists and learn about ILUMYA™ (tildrakizumab-asmn), a treatment for moderate-to-severe plaque psoriasis. This podcast episode is sponsored by Sun Pharma. For Important Safety Information: https://bit.ly/2We7fIS. For Full Prescribing Information: https://bit.ly/2xLEfil.
Discover why it's important to have guidelines addressing the use of systemic nonbiologic therapies and why oral agents still play a role now and in the future treatment of psoriatic disease from one of the country's leading prescribers, dermatologist Dr. Kenneth Gordon, Professor and Chair of Dermatology at Froedtert and Medical College of Wisconsin in Milwaukee. To view disclosure information and claim credit go to https://www.eeds.com/em/1377. This program is supported by unrestricted educational grants from Celgene and Ortho Dermatologics.
Scalp psoriasis is considered one of the more difficult to treat manifestations of psoriasis. Hear leading dermatologist Dr. Jennifer Soung, Director of Clinical Research at Southern California Dermatology in Santa Ana, CA, share her tips about managing and treating mild-to-moderate and severe scalp psoriasis. To view disclosure information and claim credit, go to https://www.eeds.com/em/1307. This program is supported by unrestricted educational grants from AbbVie, Lilly and Ortho Dermatologics.
Could inclusion of measuring psoriatic arthritis symptoms in psoriasis clinical trials be a step towards reducing the gap in diagnosis of PsA? That's a question asked of renowned rheumatologist and NPF Board Member, Dr. Elaine Husni, Vice Chair of the Department of Rheumatic and Immunologic Diseases and Director of the Arthritis and Musculoskeletal Center at the Cleveland Clinic. Hear this discussion of the JAAD article "Measuring Psoriatic Arthritis Symptoms: A Core Domain in Psoriasis Clinical Trials". To view disclosure information and claim credit, go to https://www.eeds.com/em/1275 . Article link: https://pubmed.ncbi.nlm.nih.gov/31163240/ .
From diagnosis to therapy options nail psoriasis can be a challenge to treat. Listen as leading dermatologist and NPF Medical Board Member, Dr. April Armstrong, Director of the Psoriasis Program, Dept. of Dermatology at Keck School of Medicine, USC, addresses the challenges and offers tips to help manage nail psoriasis. For disclosure information and claim credit go to https://www.eeds.com/em/1271. For more information read the JPPA article "Nail Psoriasis: A Review of Treatment Options" https://journals.sagepub.com/doi/pdf/10.1177/247553031016.00405. This activity is supported by grant funding from AbbVie, Amgen and Lilly.
Hear special guest Dr. Albert Rizzo, Chief Medical Officer at the American Lung Association and member of Christiana Care Pulmonary Associates discuss what COVID-19 means for your patients; risks, symptoms, possible treatments and overall impact moving forward. Includes a discussion of patient resources available through the American Lung Association from Chief Mission Officer, Ms. Deb Brown. For a helpful patient fact sheet with tips for using telehealth contact the National Psoriasis Foundation's Patient Navigation Center at education@psoriasis.org. To view disclosure information and claim credit, go to https://www.eeds.com/em/1170.
Hear Dr. Abby Van Voorhees, Chair of Dermatology at Eastern Virginia Medical School and Chair of the NPF's Medical Board discuss intriguing COVID-19 survey results (which includes use of biologics and systemics considerations) from key dermatologists and rheumatologists who comprise the NPF's Medical Board and Scientific Advisory Committee. Results helped shape the development of the Medical Board's "COVID-19 Recommendations for Patients With Psoriatic Disease" and could provide some peer advice on how to navigate patient care during the COVID-19 pandemic. To view disclosure information and claim credit go to https://www.eeds.com/em/1166 . View the data reference sheet mentioned in this podcast at https://bit.ly/34n4veU .
Hear the research behind this study from dermatologists Dr. Ben Kaffenberger, Dr. Jessica Kaffenberger and perioontist Dr. Purnima Kumar who seek to identify associations between oral health, hygiene, diet and psoriasis. To view disclosure information and claim credit, go to https://www.eeds.com/em/1139 .
The Biologic Fulfillment Fundamentals (BFF) Campaign from the National Psoriasis Foundation, sponsored by Janssen, supports dermatology biologic coordinators working on behalf of psoriasis patients to ensure they're able to start and stay on their prescribed biologic treatment. Hear from dermatology biologic coordinator, Leslie Lucas, and psoriasis patient, Alicia, who discuss the importance of communication and best practices to implement between patients and dermatology medical professionals when being prescribed a biologic treatment. For more information visit psoriasis.org/BFF.
What's the association between diet choices and psoriatic disease severity? Hear the evidence and current research around dietary recommendations from dermatologist Dr. April Armstrong, Director of the Psoriasis Program, Dept. of Dermatology at Keck School of Medicine, University of Southern California. To view disclosure information and claim credit, go to https://www.eeds.com/em/1138 . To access the full recommendations: https://jamanetwork.com/journals/jamadermatology/article-abstract/2684587.
Be part of the effort to evaluate the real-world use of treatments through one of the world's largest psoriasis databases, the Corrona Psoriasis Registry. Listen as Dr. Bruce Strober, Registry Scientific Co-Director and Assistant Clinical Professor of Dermatology at Yale University, New Haven, CT and dermatologist at Central Connecticut Dermatology in Cromwell, CT, talks about the important research questions which can be answered when 10,000+ patients join together with their dermatologists.
Hear the latest news about the association between psoriasis and cardiovascular disease - from lipoproteins and inflammation to the metabolic bin, and how treatments can impact health risks from cardiologist Dr. Nehal Mehta, Chief of the Section of Inflammation and Cardiometabolic Diseases at the National Institutes of Health in Bethesda, MD. To view disclosure information and claim credit, go to https://www.eeds.com/em/1137 .
Catch this guideline episode with a focus on the management and treatment of children and teens with psoriasis from Dr. Lara Wine Lee, Director of Pediatric Dermatology at the Medical University of South Carolina. Hear Dr. Wine Lee discuss the complex nature of the disease, impact of comorbidities and treatment options. To view disclosure information and claim credit go to https://www.eeds.com/em/1136 . This program is supported by unrestricted educational grants from Celgene and Ortho Dermatologics.
Listen to some fascinating results about the impact of lifestyle changes such as diet, exercise, smoking and alcohol use in the management of psoriasis and related comorbidities from Dr. Ronald Prussick, Medical Director at Washington Dermatology Center in Rockville, M.D. To view disclosure information and claim credit, go to https://www.eeds.com/em/1135 . To access a copy of Dr. Prussick's article https://bit.ly/37ODu4x .
Hear Dr. Tina Bhutani, Co-Director of the Psoriasis and Skin Treatment Center at UCSF, discuss key elements of the AAD NPF Phototherapy Guidelines, the different types of phototherapy and why phototherapy is still a tried and true treatment option for psoriasis. To view disclosure information and claim credit, go to https://www.eeds.com/em/1130 . This program is supported by unrestricted educational grants from Celgene and Ortho Dermatologics.
Hear about biosimilars, their efficacy in comparison to biologics, the current and upcoming status as a treatment for psoriasis from Dr. Grace Kimmel who completed a fellowship in dermatopharmacology and is now with the Department of Dermatology at Icahn School of Medicine at Mount Sinai. To view disclosure information and claim credit, go to https://www.eeds.com/em/1132 . This program is supported by unrestricted educational grants from Bristol-Myers Squibb, Lilly and Ortho Dermatologics. For additional CME access the article mentioned in this podcast at https://cme.psoriasis.org/content/efficacy-biosimilars-psoriasis .
Catch a conversation with Dr. Abby Van Voorhees, Chair of NPF's Medical Board and Chair of Dermatology at Eastern Virginia Medical School in Norfolk, Va, about factors to consider when patients with psoriasis and/or psoriatic arthritis are pregnant or considering pregnancy. To view disclosure information and claim credit, go to https://www.eeds.com/em/1131 . This program is supported by unrestricted educational grants from Bristol-Myers Squibb, Lilly, and Ortho Dermatologics.
Hear what may drive the mental health connection with psoriasis and psoriatic arthritis and tips you can use as a health care provider to help address such issues as depression and anxiety with your patients. Dr. Richard Fried, Clinical Director at Yardley Dermatology has the unique distinction of being both a dermatologist and a clinical psychologist. This program is supported by unrestricted educational grants from Bristol-Myers Squibb, Lilly and Ortho Dermatologics. To view disclosure information and claim credit, go to https://www.eeds.com/em/1129 .
Hear Dr. Alan Menter, Chief of Dermatology at Baylor, Scott and White Health in Dallas, TX and Co-Chair of the Guidelines Development Committee, discuss the eleven biologic agents used for the treatment of moderate-to-severe psoriasis and psoriatic arthritis. To view disclosure information and claim credit go to https://www.eeds.com/em/1121 . This program is supported by unrestricted educational grants from Celgene and Ortho Dermatologics. To access guidelines: www.aad.org/practicecenter/quality/clinical-guidelines/psoriasis .
Dr. Mark Lebwohl, the Waldman Professor and Chairman of the Kimberly and Eric J. Waldman Department of Dermatology at Icahn School of Medicine at Mount Sinai Health System in New York, discusses the latest treatment options used for rapid relief of psoriasis flares (which includes his research around response times to examples of use with patients). To view disclosure information and claim credit, go to https://www.eeds.com/em/1133 . The program is supported by unrestricted educational grants from Lilly and UCB.
Hear a discussion about the systemic nature of psoriasis and how the risk of concurrent health conditions should influence the management and treatment of psoriasis from Dr. So Yeon Paek, dermatologist with Texas Dermatology Associates and Assistant Clinical Professor of Dermatology at Texas A&M Medical School in Dallas. To view disclosure information and claim credit, go to https://www.eeds.com/em/1120 . This program is supported by unrestricted educational grants from Celgene and Ortho Dermatologics. To access the psoriasis guidelines: www.aad.org/practicecenter/quality/clinical-guidelines/psoriasis .
Hear a fascinating insight into the field of glycomics - from glycan function to the relationship to immune mediated diseases such as psoriasis from Dr. Emanual Maverakis, a dermatologist and physician investigator with the Departments of Dermatology, Medical Microbiology and Immunology at University of California, Davis. To view disclosure information and claim credit, go to https://www.eeds.com/em/1119 . This program is supported by unrestricted educational grants from Bristol-Myers Squibb, Lilly and Ortho Dermatologics.
Hear dermatologist Dr. Abby Van Voorhees, Chair of NPF's Medical Board and Chair of Dermatology at Eastern Virginia Medical School in Norfolk, VA, discuss the symptoms of psoriasis in the ear, potential impact and treatment options. To view disclosure information and claim credit, go to https://www.eeds.com/em/1118 . This program is supported by unrestricted educational grants from Bristol-Myers Squibb, Lilly and Ortho Dermatologics.
Hear rheumatologist Dr. Arthur Mandelin from Northwestern University, Feinberg School of Medicine in Chicago, compare key features and symptoms of psoriatic arthritis to rheumatoid arthritis, osteoarthritis and gout. Includes a discussion about PsA screening tools. To view disclosure information and claim credit, go to https://www.eeds.com/em/1117 . This program is supported by unrestricted educational grants from Bristol-Myers Squibb, Lilly and Ortho Dermatologics.
Hear Dr. Joel Gelfand, Director of the Psoriasis and Phototherapy Treatment Center at University of Pennsylvania, expand on his discussion of the value of phototherapy and the patient/provider requirements for becoming involved in the Light Treatment Effectiveness or LITE Study. To view disclosure information and claim credit, go to https://www.eeds.com/em/1114 . This program is supported by unrestricted educational grants from Bristol-Myers Squibb, Lilly and Ortho Dermatologics.
Dr. Nehal Mehta, a nuclear cardiologist who is Chief of the Section of Inflammation and Cardiometabolic Diseases at the National Institutes of Health in Bethesda, MD, talks about his research in understanding the role of innate immunity and inflammation in psoriatic disease, and how it relates to cardiovascular and metabolic diseases. To view disclosure information and claim credit, go to https://www.eeds.com/em/1113 . This program is supported by unrestricted educational grants from Bristol-Myers Squibb, Lilly and Ortho Dermatologics. To access other CME activities visit https://cme.psoriasis.org .
Hear what the new treatment guidelines for psoriatic arthritis from the American College of Rheumatology and the National Psoriasis Foundation may mean for management of the disease. Dr. Philip Mease, a rheumatologist and Director of the Rheumatology Clinical Research Division at Swedish Medical Center/Providence St. Joseph Health in Seattle, WA, discusses the high points of the guidelines. To view disclosure information and claim credit, go to https://www.eeds.com/em/1112 . This program is supported by unrestricted educational grants from Bristol-Myers Squibb, Lilly and Ortho Dermatologics. For additional CME education opportunities visit https://cme.psoriasis.org
Hear Dr. Amy Paller, M.D., world renowned pediatric dermatologist at Northwestern University, Feinberg School of Medicine and Director of the Northwestern University Skin Disease Research Center address the use of biologics in youth along with her research in Liproproteins and targeted topical delivery system using gene suppression and nanotherapy. To view disclosure information and claim credit, go to https://www.eeds.com/em/1110 . This program is supported by unrestricted educational grants from Bristol-Myers Squibb, Lilly and Ortho Dermatologics. For other CME education opportunities visit cme.psoriasis.org .